Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 800 mg / day) in a B.I.D. regimen
Titel:
Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 800 mg / day) in a B.I.D. regimen
Auteur:
Jones, M.W Blume, W.T Guberman, A Lee, M.A Pillay, N Weaver, D.F Veloso, F Holdich, T.A.H